CD274 and neoplasm: Preclinical work by Dovedi et al. demonstrated that combining RT with PD-1/PD-L1 blockade synergistically improves tumor control and survival, with long-term complete responses in up to 80% of treated mice (P < 0.001) compared to RT alone [33].